Home
Toolbox
Resource
Workflow
Tutorials
Citations
Downloads
Mutation Al-Predictor Flow
Gene-to-Mutation Flow
News & Insights
Genetic Encyclopedia
Frontiers
Industry Insights
Case Studies
About Us
About the Site
Contact Us
Private Policy
User Agreement
COL4A5 c.1390G>A
ALS1
DMD c.1332-11868C>G
TP53
肌萎缩侧索硬化症1型
USH2A c.8559-2A>G
囊性纤维化
Log In
|
Sign Up
中文
人类
CBL - Cbl Proto-oncogene
Alias:
CBL2
NSLL
C-CBL
RNF55
FRA11B
Create a favorites folder
Cancel
Confirm
Add To Favorites
Select a favorites
Description
New favorites >>
Cancel
Confirm
Favorite
Basic Information
Sequence Homology
Related Diseases and Mutations
Transcripts & Proteins
Gene Expression
Interactions
Related Mouse Models
Related Drugs
References Literature
这个基因是一个原癌基因,编码一个RING指E3泛素连接酶。这个编码的蛋白质是蛋白质酶体降解底物所需的酶之一。这个蛋白质调节泛素从泛素结合酶(E2)到特定底物的转移。这个蛋白质还含有一个N-末端磷酸酪氨酸结合结构域,使其能够与许多酪氨酸磷酸化底物相互作用并将其靶向蛋白酶体降解。因此,它作为许多信号传导途径的负调控子发挥作用。这个基因已被发现在许多癌症中突变或易位,包括急性髓细胞白血病,5'UTR中CGG重复扩张与雅各布森综合征有关。这个基因的突变也是诺尼唐综合征样障碍的原因。[由RefSeq,2016年7月提供]
Related ID:
NCBI:867
ENSEMBL:ENSG00000110395
HGNC:1541
UNIPROT:P22681
OMIM:165360
Basic Information
NCBI
Transcripts
Exons
Length
MW (kDa)
Mutations
Related Diseases
Related Mouse Models
Reference
867
1
16
101811 bp
99.63
1299
8
15
57
CBL Genetics information (+)
GRCh38
Sequence Homology
Related Diseases and Mutations
#
Disease
Anatomical Category
Score
Mutations
No data available
Transcripts & Proteins
Table View
Tile View
#
Transcript
Length(nt)
Exon Count
CDS(bp)
Protein
Length(aa)
No data available
* This data comes from NCBI.
Gene Expression
Tissue-specific RNA expression
Organ
Abundance
Alphabetical
Cell-specific RNA expression
Organ
Abundance
Alphabetical
Interactions
Reset
Acting
Regulation
Detail
Mechanism
Target
Residues
Reference
Score
No data available
Related Mouse Models
Type
Name
MGI
Strain of Origin
Publications
Mutations
No data available
Related Drugs
Name
CAS Number
Status
Phase
Link
No data available
References Literature
Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Mutation Direct
Sequence
Comparison
Al agent
Tutorials
Back to top